BCS expands offering with gene therapy reinsurance solutions
Reinsurance News - Nov 28, 2023
BCS Financial has expanded its stop loss and reinsurance offerings to include new payer solutions in response to the growing gene therapy pipeline. Peter Costello, BCS President & Chief Executive Officer, commented, “Gene therapies offer the promise of potential cures, but with treatment c...
Recommended Articles
Posted: Apr 10, 2026
Jean‑Jacques Henchoz, the former Chief Executive Officer of large European reinsurer Hannover Re, ha...
Posted: Apr 10, 2026
Liberty Mutual Insurance has announced the establishment of a $600 million endowment for Liberty Mut...
Posted: Apr 10, 2026
As demand for artificial intelligence (AI) talent and roles intensifies across industries, global in...